Tiziana Life Sciences TLSA
NASDAQ TLSA
$0.96 -0.01 (-1.30%)
At close: Sep 10, 2026 · 4:00 PM EDT

Tiziana Life Sciences (TLSA) Total Liabilities (2017 - 2025)

Tiziana Life Sciences (TLSA) posted Total Liabilities of $11.4 million for Q4 2025, up 54.7% on a QoQ basis from $7.4 million in Q2 2025, and up 55.73% year-over-year from $7.3 million in Q4 2024.

Analysis

Tiziana Life Sciences (TLSA) Total Liabilities (2017 - 2025) Analysis & Trends

Tiziana Life Sciences has reported Total Liabilities for 9 years, with the latest figure at $11.4 million in Q4 2025.

  • On a quarterly basis, Total Liabilities rose 55.73% year-over-year to $11.4 million in Q4 2025; TTM through Dec 2025 was $11.4 million, a 55.73% increase from a year earlier, with the FY2025 full-year figure at $11.4 million, up 55.73% from the prior year.
  • Total Liabilities was $11.4 million for Q4 2025 at Tiziana Life Sciences, up from $7.4 million in the prior quarter.
  • The five-year high for Total Liabilities was $11.4 million in Q4 2025, with the low at $4.1 million in Q2 2023.
  • Average Total Liabilities over 5 years is $7.5 million, with a median of $7.4 million recorded in 2024.
  • The sharpest annual moves came in 2022 and 2024: Total Liabilities tumbled 42.41% in 2022, then surged 120.93% in 2024.
  • Over 5 years, Total Liabilities stood at $7.5 million in 2021, then retreated by 8.48% to $6.9 million in 2022, then dropped by 3.74% to $6.6 million in 2023, then increased by 10.53% to $7.3 million in 2024, then soared by 55.73% to $11.4 million in 2025.
  • The last three Total Liabilities figures came in at $11.4 million (Q4 2025), $7.4 million (Q2 2025), and $7.3 million (Q4 2024), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 83.95 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 37.53 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 7.18 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 10.02 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 1.62 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 4.20 Bn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 4.20 Bn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 13.24 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 384.62 Mn
10 Tiziana Life Sciences 113.92 Mn 113.92 Mn - 11.44 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 11.44 Mn
Jun 30, 2025 7.40 Mn
Dec 31, 2024 7.35 Mn
Jun 30, 2024 9.11 Mn
Dec 31, 2023 6.65 Mn
Jun 30, 2023 4.12 Mn
Dec 31, 2022 6.91 Mn
Jun 30, 2022 5.28 Mn
Dec 31, 2021 7.55 Mn
Jun 30, 2021 9.16 Mn
Dec 31, 2020 8.27 Mn
Jun 30, 2020 6.89 Mn
Dec 31, 2019 7.70 Mn
Jun 30, 2019 6.55 Mn
Dec 31, 2018 6.47 Mn
Jun 30, 2018 6.17 Mn
Dec 31, 2017 4.67 Mn